C07D 311 - Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings

Patents for C07D 311 - Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings (24,127)
10/2009
10/29/2009	WO2009130253A1 Chromenone derivatives useful for the treatment of neurodegenerative diseases
10/29/2009	WO2009096702A9 Novel organic dye and method for preparing same
10/29/2009	US20090269793 Compounds and Kits for the Detection and the Quantification of Cell Apoptosis
10/29/2009	US20090267026 Compound having hydrocoumarin skeleton, liquid crystal composition, and liquid crystal display device
10/29/2009	US20090265866 Xanthene Dyes
10/28/2009	EP2112145A1 Chromenone derivatives useful for the treatment of neurodegenerative diseases
10/28/2009	EP2111399A2 Naphthalenone compounds exhibiting prolyl hydroxylase inhibitory activity, compositions, and uses thereof
10/28/2009	CN101568528A Solvent addition and removal in the hydrogenation of catmint oil
10/28/2009	CN101565414A Method for extracting and separating procyanidine
10/28/2009	CN101565413A Isoflavone derivative modified by acetylaminoacid benzyl ester, preparation method and application thereof
10/28/2009	CN100554261C Myricitrin preparing process
10/27/2009	US7608638 Tocopherols, tocotrienols, other chroman and side chain derivatives and uses thereof
10/27/2009	US7608564 Herbicide; in crops such as wheat, rice, maize, soybeans and cotton they act against broad-leaved weeds and grass weeds without damaging the crop plants; compounds are based on 3-(5,5-disubstituted 2-isoxazolin-3-yl)benzoic acid, esters, thioesters and pyrazolyl ketones thereof
10/27/2009	CA2381885C Isomeric fused pyrrolocarbazoles and isoindolones
10/27/2009	CA2318976C Herbicidally active 3-hydroxy-4-aryl-5-oxopyrazoline derivatives
10/22/2009	US20090264664 Preparation for external application comprising salt of mast cell degranulation inhibitor having carboxyl group with organic amine
10/22/2009	US20090264519 Insulin sensitivity improving agent
10/22/2009	US20090264424 Vanilloid receptor ligands and their use in treatments
10/22/2009	US20090263509 Antibacterial agent and antibacterial composition
10/22/2009	CA2721191A1 Calycosin and analogs thereof for the treatment of estrogen receptor beta-mediated diseases
10/21/2009	EP2110134A1 Cocoa extract compounds and methods for making and using the same
10/21/2009	EP2109606A1 Chromene s1p1 receptor antagonist
10/21/2009	EP1395615B1 Oxime ester photoinitiators having a combined structure
10/21/2009	EP1162968B1 Epigallocatechin-gallate for inhibiting angiogenesis
10/21/2009	CN101563335A Hydrogenation of catmint oil
10/21/2009	CN101563334A Production of dihydronepetalactone by hydrogenation of nepetalactone
10/21/2009	CN101563318A N- (5, 6, 7, 8-tetrahydronaphthalen-1-yl) urea derivatives and related compounds as trpv1 vanilloid receptor antagonists for the treatment of pain
10/21/2009	CN101560201A Technique for extracting high purity puerarin and diverse rare medical components from root of kudzuvine
10/21/2009	CN100551921C Use of brasilein
10/20/2009	US7605111 Herbicides
10/20/2009	CA2330128C Food compositions, compositions for oral cavity and medicinal compositions for preventing or treating periodontosis and method for preventing or treating periodontosis
10/15/2009	WO2009124909A1 Use of xanthone derivatives as a medicament for cancer
10/15/2009	US20090259085 Semi-Rigid Linked Diamines, Precursors Therefor, And Transition Metal Diamido Complexes As Catalysts For Olefin Polymerization Processes
10/15/2009	US20090259055 Catalytic enantioselective synthesis of flavanones and chromanones
10/15/2009	US20090259054 Methods and Compositions for the Treatment of Angiogenesis and Macular Degeneration
10/15/2009	US20090258942 Calycosin and analogs thereof for the treatment of estrogen receptor beta-mediated diseases
10/15/2009	US20090258939 Pyrone analog compositions and methods
10/15/2009	US20090257953 Novel fluorine-18 labeled rhodamine derivatives for myocardial perfusion imaging with positron emission tomography
10/14/2009	EP2108645A1 Use of xanthone derivatives as a medicament for cancer
10/14/2009	CN101557702A Hybrid maize with uniform concentration of anthocyanins of easy extraction and process for the extration of anthocianins from hybrid maize
10/14/2009	CN101555241A Ampelopsin pro-dug and preparing method and application thereof
10/14/2009	CN101555240A Chemical synthesis method of flavonoid compound
10/14/2009	CN100548960C Substituted 1,3-diphenylprop-2-en-1-one derivatives and preparation and uses thereof
10/14/2009	CN100548940C One and two step ultracritical fluid extraction of carotene, VE and other trace element concentration
10/13/2009	US7601855 Substituted chroman derivatives, medicaments and use in therapy
10/13/2009	US7601851 Compounds and methods for fluorescent labeling
10/13/2009	US7601754 7-Ethyl-3-hydoxy-2-(3,4,5-trihydoxy-phenyl)-chromen-4-one, for example; exhibits anti-oxidative properties in biological systems; utility in a sunscreen or skincare composition or to treat conditions involving oxidative damage, especially curative or prophylactic treatment of Alzheimer's disease
10/13/2009	CA2368274C C10 ester substituted taxanes as antitumor agents
10/13/2009	CA2355098C Chroman derivatives
10/13/2009	CA2341678C Potassium channel inhibitors and method
10/08/2009	WO2009124024A1 Compositions and methods for inhibition of hepatocyte growth factor receptor c-met signaling
10/08/2009	WO2009121710A2 Process for preparing nebivolol
10/08/2009	WO2009121247A1 Luminescence quenchers and fluorogenic probes for detection of reactive species
10/08/2009	WO2009121244A1 Fluorophore compounds
10/08/2009	WO2009121228A2 A lubiprostone crystal, its preparation process and its use
10/08/2009	US20090253919 Chiral thiourea compounds and process for enantioselective reduction of ketones
10/08/2009	US20090253783 Production of Delta 9 Tetrahydrocannabinol
10/08/2009	CA2714051A1 Process for preparing nebivolol
10/07/2009	EP2107055A1 Diosmetin derivatives, process for their preparation and pharmaceutical compositions containing them
10/07/2009	CN101553472A Tetrahydronaphthaline derivatives, methods for the production and use thereof as anti-inflammatory agents
10/07/2009	CN101550125A Hazelnut element B, extracting method and pharmaceutical use thereof
10/07/2009	CN101550124A Diosmetin compounds, a process for their preparation and pharmaceutical composition containing them
10/07/2009	CN101550120A Effective component of artemisia leaves and preparation method thereof
10/07/2009	CN101550072A Effective component of cogongrass rhizome and preparation method thereof
10/07/2009	CN100546987C Process for preparing DL-nebivolol and its hydrochloride
10/06/2009	US7598403 6-Hydroxy-2,2-dimethyl-chroman-4-one; anticancer agents; bioavailability
10/06/2009	US7598242 Compounds for the treatment of inflammatory disorders
10/06/2009	US7596836 Antiviral solution; alcohol, a surfactant, an essential oil, an hygroscopic substance, a buffered acid, water.
10/01/2009	WO2009120191A1 Process for the preparation of benzo-fused heteroaryl sulfamates and crystalline form of n- ( ( (2s) -6-chloro-2,3-dihydro-l,4-benzodioxin-2-yl) methyl-sulfamide
10/01/2009	WO2009060835A8 Novel ubiquilin-binding small molecule
10/01/2009	US20090247621 Diosmetin compounds, a process for their preparation and pharmaceutical composition containing them
10/01/2009	US20090247620 Benzochromene Derivatives for Use in Liquid Crystal Media and as Therapeutic Active Substances
10/01/2009	US20090247616 Use of benzo-fused heterocyle sulfamide derivatives for the treatment of anxiety
10/01/2009	US20090247524 HSP90 Inhibitor
10/01/2009	US20090247506 Antibacterial agents
10/01/2009	CA2719624A1 Process for the preparation of benzo-fused heteroaryl sulfamates and crystalline form of n- ( ( (2s) -6-chloro-2,3-dihydro-1,4-benzodioxin-2-yl) methyl-sulfamide
09/2009
09/30/2009	EP2105440A2 Actinic ray-sensitive or radiation-sensitive resin composition, pattern forming method using the same, polymerizable compound and polymer compound obtained by polymerizing the polymerizable compound
09/30/2009	EP2105432A1 Process for Producing Chromone Compound
09/30/2009	EP2105431A1 Process for Producing Chromone Compound
09/30/2009	EP2104668A2 Solvent addition and removal in the hydrogenation of catmint oil
09/30/2009	EP2104667A2 Synthesis of chromane derivatives in the presence of ionic liquids
09/30/2009	CN101544626A Method for extracting genistein from plant nepeta japonica maxim
09/30/2009	CN100545158C (3R,4R)-trans-3,4-diarylchroman derivatives with estrogenic activity
09/30/2009	CN100545157C Method for separating and purifying flavone from artemisia selengensis by simulating moving bed chromatography
09/29/2009	US7595343 Inhibitors of histone deacetylase
09/29/2009	US7595162 Methods of labeling polynucleotides with energy transfer dyes
09/29/2009	CA2464042C Mptp affinity labels
09/29/2009	CA2348391C Chromenone and chromanone derivatives as integrin inhibitors
09/24/2009	WO2009116883A2 Catalytic asymetric hydrogenation
09/24/2009	WO2009115051A1 Antifouling method and composition using chromen-4-one derivatives
09/24/2009	WO2009086509A3 Reagents for biomolecular labeling, detection and quantification employing raman spectroscopy
09/24/2009	WO2008044246A3 A process for the preparation of warfarin sodium
09/24/2009	WO2005113533A9 Process for preparing unsaturated lactones
09/24/2009	US20090240070 Whitening dermatological preparations
09/24/2009	US20090239916 Novel drug discovery target and medicine acting on the same
09/24/2009	US20090238765 Fluorescent Contrast Agent
09/24/2009	CA2716694A1 Process
09/23/2009	EP2103300A1 Cosmetic
09/23/2009	EP2102196A1 Process for preparing nebivolol
09/23/2009	EP2102182A2 Catalytic process for asymmetric hydrogenation

1 ... 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 ... 242